Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bellet

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Blood Advances|July 30, 2020
Rapidly expanded partially HLA DRB1-matched fungus-specific T cells mediate in vitro and in vivo antifungal activityGloria Castellano-González, Helen M McGuire, Fabio Luciani, et al.
Nature Communications|September 16, 2023
Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumoniaGiorgia Renga, Fiorella D'Onofrio, Marilena Pariano, et al.
Nature Communications|April 26, 2024
Author Correction: Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumoniaGiorgia Renga, Fiorella D'Onofrio, Marilena Pariano, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|January 22, 2019
Changes in dietary intake, plasma carotenoids and erythrocyte membrane fatty acids in breast cancer survivors after a lifestyle intervention: results from a single-arm trialG Buckland, N Travier, L Arribas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 7, 2011
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysisJ Cortes, V Calvo, N Ramírez-Merino, et al.
International Journal of Molecular Sciences|July 2, 2021
Anakinra Activates Superoxide Dismutase 2 to Mitigate Inflammasome ActivityMarilena Pariano, Stefania Pieroni, Antonella De Luca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysisJ Cortes, V Calvo, N Ramírez-Merino, et al.
Nature Medicine|April 11, 2017
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisLuigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
ESMO Open|June 18, 2025
Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trialA Llombart-Cussac, J M Pérez-García, M Bellet, et al.
Nature Medicine|June 24, 2018
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisLuigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Blood Advances|July 30, 2020
Rapidly expanded partially HLA DRB1-matched fungus-specific T cells mediate in vitro and in vivo antifungal activityGloria Castellano-González, Helen M McGuire, Fabio Luciani, et al.
Nature Communications|September 16, 2023
Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumoniaGiorgia Renga, Fiorella D'Onofrio, Marilena Pariano, et al.
Nature Communications|April 26, 2024
Author Correction: Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumoniaGiorgia Renga, Fiorella D'Onofrio, Marilena Pariano, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|January 22, 2019
Changes in dietary intake, plasma carotenoids and erythrocyte membrane fatty acids in breast cancer survivors after a lifestyle intervention: results from a single-arm trialG Buckland, N Travier, L Arribas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 7, 2011
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysisJ Cortes, V Calvo, N Ramírez-Merino, et al.
International Journal of Molecular Sciences|July 2, 2021
Anakinra Activates Superoxide Dismutase 2 to Mitigate Inflammasome ActivityMarilena Pariano, Stefania Pieroni, Antonella De Luca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysisJ Cortes, V Calvo, N Ramírez-Merino, et al.
Nature Medicine|April 11, 2017
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisLuigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
ESMO Open|June 18, 2025
Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trialA Llombart-Cussac, J M Pérez-García, M Bellet, et al.
Nature Medicine|June 24, 2018
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisLuigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
Pageof 16